rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2009-11-9
|
pubmed:abstractText |
To evaluate the impact of the clinical target volume (CTV) and fraction dose on quality of life (QoL) after external-beam radiotherapy (EBRT) for prostate cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1439-099X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
185
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
724-30
|
pubmed:meshHeading |
pubmed-meshheading:19899005-Aged,
pubmed-meshheading:19899005-Aged, 80 and over,
pubmed-meshheading:19899005-Dose Fractionation,
pubmed-meshheading:19899005-Erectile Dysfunction,
pubmed-meshheading:19899005-Fecal Incontinence,
pubmed-meshheading:19899005-Follow-Up Studies,
pubmed-meshheading:19899005-Humans,
pubmed-meshheading:19899005-Male,
pubmed-meshheading:19899005-Middle Aged,
pubmed-meshheading:19899005-Prospective Studies,
pubmed-meshheading:19899005-Prostate,
pubmed-meshheading:19899005-Prostate-Specific Antigen,
pubmed-meshheading:19899005-Prostatic Neoplasms,
pubmed-meshheading:19899005-Quality of Life,
pubmed-meshheading:19899005-Questionnaires,
pubmed-meshheading:19899005-Radiation Injuries,
pubmed-meshheading:19899005-Radiotherapy Dosage,
pubmed-meshheading:19899005-Rectum,
pubmed-meshheading:19899005-Seminal Vesicles,
pubmed-meshheading:19899005-Tumor Markers, Biological,
pubmed-meshheading:19899005-Urinary Bladder,
pubmed-meshheading:19899005-Urinary Incontinence
|
pubmed:year |
2009
|
pubmed:articleTitle |
Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer.
|
pubmed:affiliation |
Department of Radiotherapy, RWTH Aachen, Aachen, Germany. mpinkawa@ukaachen.de
|
pubmed:publicationType |
Journal Article,
Comparative Study
|